The future of cancer diagnosis may lie in just a few milliliters of blood, according to a research team led by Professor Arie Admon of the Technion-Israel Institute of Technology. In a study released this week in the Proceedings of the National Academy of Sciences, the scientists report on a new source of blood-derived biomarkers that could soon help doctors determine whether a recovering cancer patient has relapsed, and may someday aid in the early detection of a variety of cancers...
No comments:
Post a Comment